Imodium Plus

Loperamide Hydrochloride and Dimeticone, the active ingredients in Imodium Plus, are antidiarrheal agents presented as an oral tablet for oral use. They relieve acute nonspecific diarrhea, traveler’s diarrhea, and gastrointestinal upset with gas or bloating.

GNH USA supplies Imodium Plus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Imodium Plus, an antidiarrheal medication, works on the gastrointestinal tract to manage diarrheal conditions.

- Acute nonspecific diarrhea: reduces stool frequency and improves stool consistency. - Traveler's diarrhea: provides symptomatic relief for travelers experiencing sudden loose stools. - Gastrointestinal upset with gas/bloating: alleviates bloating and discomfort associated with excess intestinal gas.

Common Side Effects: - Constipation: reduced bowel movements or hard stools. - Abdominal cramps: mild to moderate discomfort in the abdomen. - Nausea: feeling of queasiness or urge to vomit. - Flatulence: increased intestinal gas. - Dizziness: light‑headed sensation. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Severe constipation or paralytic ileus: risk of bowel obstruction. - Allergic reactions: rash, itching, swelling, or hives. - Toxic megacolon: extreme dilation of the colon. - Severe abdominal pain: persistent or worsening pain. - Cardiac arrhythmia: irregular heartbeat (rare). - Anaphylaxis: life‑threatening allergic response.

Before using Imodium Plus, consider the following precautions. - Dosage adjustment: reduce dose in patients with hepatic impairment. - Hydration: maintain adequate fluid intake to prevent dehydration. - Avoid use: do not use in bacterial enterocolitis with fever or blood in stool. - Caution in children: use only under medical supervision. - Drug interactions: review concomitant medications for potential interactions. - Store at ambient temperature: keep in the original pack, protect from moisture and heat.

Imodium Plus may interact with other medicines; monitor accordingly.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase loperamide plasma levels. - Concurrent antidiarrheals: risk of excessive constipation. - P‑gp inhibitors (e.g., quinidine): can raise systemic exposure.

Moderate Interactions (Monitor Closely): - Anticholinergic agents: may worsen constipation. - Antihistamines (e.g., diphenhydramine): may increase drowsiness. - Macrolide antibiotics (e.g., erythromycin): potential CYP3A4‑mediated interaction.